Cannabis Capital Raise LLC
Cannabis Private Equity
We show private equity issuers how to most quickly and cheaply raise capital under SEC Regulation D Rule 506(c and other JOBS Act exemptions.
Do you own or manage a cannabis commerce company
that has raised some capital organically and is now ready for more? Email [email protected].
Are you interested in cannabis investing opportunities? Email in confidence [email protected].
Cannabis Capital Raise LLC is a Hawaii-based financial consulting firm with part-time offices in Palo Alto. We work with marijuana entrepreneurs to identify and secure private equity.
CANADIAN CROSS-BORDER OFFERINGS
Canadian issuers of cannabis private equity seeking access to U.S. capital must satisfy Regulation S under the JOBS Act.
Regulation S provides a safe harbor for securities in offshore transactions with no directed selling efforts in the U.S. The term “directed selling efforts” means anything could have the effect of “conditioning” the U.S. market for the offering. Any press releases or other publicity surrounding the cannabis offering must not be disseminated in the U.S. There must be a prominent legend on the securities saying that the offering is not available to U.S. citizens.
Typically, U.S. investors are sought in the same time period. This “cross-border offering” is actually two separate offerings marketed in parallel on both sides of the border.
The SEC exemptions that cannabis offerings usually rely on for the U.S. portion of their cross-border offerings are Rule 506(b and Rule 506(c under Regulation D. Under Rule 506(c private cannabis shares can be offered to anyone anywhere in almost any manner: A virtual Wild West for early stage capital; to wit, in early 2018, a REIT used Rule 506(c to raise capital on Craigslist. The only catch is that any sales must be to accredited investors. Still, issuers can indiscriminately solicit investors online (and elsewhere) for any legal service or deliverable.
Practice note: Once an issuer uses 506(c, it cannot convert the offering to a 506(b; however, it can convert a 506(b offering into a 506(c offering.
Rule 506(b, sometimes referred to as the “Friends and Family Exemption,” permits the issuer to sell shares to 35 non-accredited investors as well as to any number of accredited investors. The downside is that Rule 506(b cannot be used if the issuer wants to solicit the public.
As for re-sales, Rule 144A provides an exemption for QIBs (Qualified InstitutionalBuyers), which include U.S. insurance companies, investment companies, certain employee benefit plans, trusts, broker-dealers, and large banks. A cannabis private placement (as well as any private equity transaction) can be followed by a resale to a QIB. For example, a fully underwritten cannabis offering could be sold to a syndicate of initial purchasers who in turn can sell shares to one or more QIBs.
Questions? Contact [email protected]